• small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • small-logo-tag

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Investors Overview

CORPORATE PROFILE

MiMedx® is an integrated developer, processor and marketer of patent protected and proprietary regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues and human skin and bone. “Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. The MiMedx allograft product families include our: dHACM family with AmnioFix®, EpiFix® and EpiBurn® brands; Amniotic Fluid family with OrthoFlo brand; Umbilical family with EpiCord™ and AmnioCord™ brands; Placental Collagen family with CollaFix™ and AmnioFill™ brands; Bone family with Physio® brand; and Skin family with AlloBurn™ brand. AmnioFix, EpiFix, and EpiBurn are our tissue technologies processed from human amniotic membrane; OrthoFlo is an amniotic fluid derived allograft; EpiCord™ and AmnioCord™ are derived from the umbilical cord; Physio is a unique bone grafting material comprised of 100% bone tissue with no added carrier; AlloBurn is a skin product derived from human skin designed for the treatment of burns; and CollaFix, our next brand we plan to commercialize, is our collagen fiber technology, developed with our patented cross-linking polymers, designed to mimic the natural composition, structure and mechanical properties of musculoskeletal tissues in order to augment their repair. We process the human amniotic membrane utilizing our proprietary PURION® Process, to produce a safe and effective implant. MiMedx proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. MiMedx is the leading supplier of amniotic tissue, having supplied over 700,000 allografts to date for application in the Wound Care, Burn, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare.

MIMEDX GROUP INC(Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$9.09
Change Stock is Up 0.03 (0.33%)
Volume445,886

12/02/16  4:00 p.m. ET

Minimum 20 minute delay
Stock chart for: MDXG.O.  Currently trading at $9.09 with a 52 week high of $10.02 and a 52 week low of $6.64.
Data Provided by Thomson Reuters

NEWS AND EVENTS

View All
Nov-18-2016
MiMedx to Present at the 28th Annual Piper Jaffray Healthcare ConferenceMARIETTA, Ga., Nov. 18, 2016 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to

Read More

Nov-11-2016
MiMedx To Present At The Canaccord|Genuity Medical Technology And Diagnostics ForumMARIETTA, Ga., Nov. 11, 2016 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to

Read More

Nov-03-2016
Mimedx Announces U.S. Pharmacopeia Monograph For dHACM Allografts Has PublishedMIMEDX'S PURION PROCESSED dHACM ALLOGRAFTS REPRESENT YEARS OF SCIENTIFICRIGOR THAT CONFORM TO THE NEW USP–NF MONOGRAPH Marietta, Georgia , November 3, 2016, (PR Newswire) ‐‐ MiMedx G

Read More

RECEIEVE E-MAIL ALERTS

Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever MIMEDX GROUP INC posts new information to the site. Just enter your e-mail address and click Submit.
 

PRODUCTS

Products

CONTACT US

888.543.1917

Products

CONTACT US

888.543.1917